Ohsaki Y - Search Results

1

EGFR and KRAS Mutations in Triple-Mutated Lung Cancer.

Yoshida R, Sasaki T, Ohsaki Y. Yoshida R, et al. Among authors: ohsaki y. J Thorac Oncol. 2017 Jul;12(7):e92-e93. doi: 10.1016/j.jtho.2017.02.022. J Thorac Oncol. 2017. PMID: 28629545 Free article. No abstract available.

2

Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation.

Okumura S, Sasaki T, Minami Y, Ohsaki Y. Okumura S, et al. Among authors: ohsaki y. J Thorac Oncol. 2012 Jan;7(1):49-56. doi: 10.1097/JTO.0b013e318233d686. J Thorac Oncol. 2012. PMID: 22089115 Free article.

3

Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts.

Sasaki T, Tanno S, Shibukawa K, Osanai S, Kawabe J, Ohsaki Y. Sasaki T, et al. Among authors: ohsaki y. Int J Oncol. 2008 Sep;33(3):525-32. Int J Oncol. 2008. PMID: 18695882

4

Prostaglandin I2 analog suppresses lung metastasis by recruiting pericytes in tumor angiogenesis.

Minami Y, Sasaki T, Bochimoto H, Kawabe J, Endo S, Hira Y, Watanabe T, Okumura S, Hasebe N, Ohsaki Y. Minami Y, et al. Among authors: ohsaki y. Int J Oncol. 2015 Feb;46(2):548-54. doi: 10.3892/ijo.2014.2783. Epub 2014 Nov 28. Int J Oncol. 2015. PMID: 25434699

5

Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer.

Yoshida R, Sasaki T, Minami Y, Hibino Y, Okumura S, Sado M, Miyokawa N, Hayashi S, Kitada M, Ohsaki Y. Yoshida R, et al. Among authors: ohsaki y. Int J Oncol. 2017 Nov;51(5):1533-1540. doi: 10.3892/ijo.2017.4140. Epub 2017 Sep 28. Int J Oncol. 2017. PMID: 29048652

6

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report.

Narumi Y, Yoshida R, Minami Y, Yamamoto Y, Takeguchi S, Kano K, Takahashi K, Saito T, Sawada J, Terui H, Katayama T, Sasaki T, Ohsaki Y. Narumi Y, et al. Among authors: ohsaki y. BMC Cancer. 2018 Jan 24;18(1):95. doi: 10.1186/s12885-018-3997-2. BMC Cancer. 2018. PMID: 29361915 Free PMC article.

7

Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR.

Yoshida R, Sasaki T, Umekage Y, Tanno S, Ono Y, Ogata M, Chiba S, Mizukami Y, Ohsaki Y. Yoshida R, et al. Among authors: ohsaki y. BMC Cancer. 2018 Nov 19;18(1):1136. doi: 10.1186/s12885-018-5031-0. BMC Cancer. 2018. PMID: 30453899 Free PMC article.

8

PD-1 Blockers: Staying Long in the Body and Delayed Toxicity Risks.

Fukudo M, Sasaki T, Ohsaki Y. Fukudo M, et al. Among authors: ohsaki y. J Thorac Oncol. 2020 Mar;15(3):e42-e44. doi: 10.1016/j.jtho.2019.11.015. J Thorac Oncol. 2020. PMID: 32093860 Free article. No abstract available.

9

The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer.

Okazaki S, Sasaki T, Yasuda S, Abe M, Yoshida N, Yoshida R, Ishibashi K, Minami Y, Okumura S, Chiba S, Takei H, Hayashi R, Nagato T, Kobayashi H, Sugitani A, Ono Y, Mizukami Y, Kitada M, Ohsaki Y. Okazaki S, et al. Among authors: ohsaki y. Oncol Lett. 2021 May;21(5):420. doi: 10.3892/ol.2021.12681. Epub 2021 Mar 28. Oncol Lett. 2021. PMID: 33841581 Free PMC article.

10

High incidence of chromosomal abnormalities at 1p36 and 9p21 in early-stage central type squamous cell carcinoma and squamous dysplasia of bronchus detected by autofluorescence bronchoscopy.

Shibukawa K, Miyokawa N, Tokusashi Y, Sasaki T, Osanai S, Ohsaki Y. Shibukawa K, et al. Among authors: ohsaki y. Oncol Rep. 2009 Jul;22(1):81-7. doi: 10.3892/or_00000409. Oncol Rep. 2009. PMID: 19513508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters